1. Home
  2. BLTE vs ENVA Comparison

BLTE vs ENVA Comparison

Compare BLTE & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • ENVA
  • Stock Information
  • Founded
  • BLTE 2018
  • ENVA 2011
  • Country
  • BLTE United States
  • ENVA United States
  • Employees
  • BLTE N/A
  • ENVA N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • BLTE Health Care
  • ENVA Finance
  • Exchange
  • BLTE Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • BLTE 2.1B
  • ENVA 2.4B
  • IPO Year
  • BLTE 2022
  • ENVA N/A
  • Fundamental
  • Price
  • BLTE $66.70
  • ENVA $96.00
  • Analyst Decision
  • BLTE Strong Buy
  • ENVA Buy
  • Analyst Count
  • BLTE 4
  • ENVA 8
  • Target Price
  • BLTE $96.67
  • ENVA $110.14
  • AVG Volume (30 Days)
  • BLTE 53.3K
  • ENVA 246.5K
  • Earning Date
  • BLTE 03-17-2025
  • ENVA 04-22-2025
  • Dividend Yield
  • BLTE N/A
  • ENVA N/A
  • EPS Growth
  • BLTE N/A
  • ENVA 35.34
  • EPS
  • BLTE N/A
  • ENVA 7.43
  • Revenue
  • BLTE N/A
  • ENVA $1,239,007,000.00
  • Revenue This Year
  • BLTE N/A
  • ENVA $155.12
  • Revenue Next Year
  • BLTE N/A
  • ENVA $13.07
  • P/E Ratio
  • BLTE N/A
  • ENVA $12.94
  • Revenue Growth
  • BLTE N/A
  • ENVA 19.69
  • 52 Week Low
  • BLTE $31.01
  • ENVA $57.46
  • 52 Week High
  • BLTE $86.53
  • ENVA $117.56
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 58.99
  • ENVA 45.11
  • Support Level
  • BLTE $64.10
  • ENVA $95.51
  • Resistance Level
  • BLTE $67.40
  • ENVA $103.11
  • Average True Range (ATR)
  • BLTE 2.33
  • ENVA 3.22
  • MACD
  • BLTE -0.33
  • ENVA 1.07
  • Stochastic Oscillator
  • BLTE 37.74
  • ENVA 57.22

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: